FDA — authorised 22 May 1998
- Application: NDA020577
- Marketing authorisation holder: LUKARE MEDICAL LLC
- Indication: Manufacturing (CMC)
- Status: approved
FDA authorised Magnesium Sulfate In Dextrose 5% In Plastic Container on 22 May 1998
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 22 May 1998; FDA authorised it on 2 March 2016; FDA authorised it on 7 March 2016.
LUKARE MEDICAL LLC holds the US marketing authorisation.